Abstract.
A 16-year-old female had mutations in both alleles of the gene encoding her sodium-chloride cotransporter; one of these mutations is newly described. Her clinical findings were not typical because of the absence of hypocalciuria in 24-h urine samples, her maximum urine osmolality (Uosm) was only 802 mosmol/kg H2O, and her plasma magnesium (Mg) concentration (PMg) was easily maintained in the normal range with oral Mg supplements for 1 month. In detailed studies, the calcium/creatinine ratio in spot urines with a Uosm >700 mosmol/kg H2O was very low, except during Mg therapy. Renal medullary function did not appear to be compromised because she had a non-urea Uosm of ~600 mosmol/kg H2O, reflecting a very high non-urea osmole excretion rate (due to KCl supplements). At age 18 years, her PMg became persistently low despite Mg therapy. We conclude that the clinical criteria for a provisional diagnosis of Gitelman syndrome should be revised. Hypocalciuria may only be evident initially in concentrated spot urine samples. Urine concentrating ability should include an analysis of the non-urea Uosm, especially when patients are taking large KCl supplements.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Ring, T., Knoers, N., Oh, M.S. et al. Reevaluation of the criteria for the clinical diagnosis of Gitelman syndrome. Pediatr Nephrol 17, 612–616 (2002). https://doi.org/10.1007/s00467-002-0898-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-002-0898-y